Dexcel Pharma Technologies Ltd.

Insider Reports History

Location
Or Akiva, Israel
Signature
/s/ Dexcel Pharma Technologies Ltd. by Dan Oren, Executive Chairman
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dexcel Pharma Technologies Ltd.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Roivant Sciences Ltd. 10%+ Owner Common Shares 102,849,443 $1,064,491,735 $10.35 10 Nov 2022 Direct
Protalix BioTherapeutics, Inc. 10%+ Owner Common Stock 3,637,314 $5,128,613 $1.41 03 Jun 2021 Direct

Insider Reports Filed by Dexcel Pharma Technologies Ltd.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ROIV Roivant Sciences Ltd. 10 Nov 2022 1 +$20,000,000 4 10%+ Owner 14 Nov 2022, 07:40
ROIV Roivant Sciences Ltd. 22 Apr 2022 2 +$154,954 4 10%+ Owner 26 Apr 2022, 06:48
ROIV Roivant Sciences Ltd. 01 Oct 2021 0 $0 3 10%+ Owner 01 Oct 2021, 17:02
PLX Protalix BioTherapeutics, Inc. 02 Jun 2021 2 -$2,088,857 4 10%+ Owner 03 Jun 2021, 17:40